Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-08-07

Clinical Trial Results: Single Dose Azithromycin to Prevent Cholera in Children [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating a single-dose azithromycin to prevent cholera in children have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Cholera | Phase 2 | Status: COMPLETED | Results posted: 2026-08-07